« Back to Record
Citation APA

Lambertini, M., Fielding, S., Loibl, S., Janni, W., Clark, E., Franzoi, M. A., Fumagalli, D., Caballero, C., Arecco, L., Salomoni, S., Pondé, N., Poggio, F., Kim, H. J., Villarreal-Garza, C., Pagani, O., Paluch-Shimon, S., Ballestrero, A., Del Mastro, L., Piccart-Gebhart, M., Bines, J., Partridge, A. A., & de Azambuja, E. (2022). Impact of Age on Clinical Outcomes and Efficacy of Adjuvant Dual Anti-HER2 Targeted Therapy. Journal of the National Cancer Institute, 114(8), 1117-1126. doi:10.1093/jnci/djac096


Permalink

http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/349699

Lambertini, M., Fielding, S., Loibl, S., Janni, W., Clark, E., Franzoi, M. A., Fumagalli, D., Caballero, C., Arecco, L., Salomoni, S., Pondé, N., Poggio, F., Kim, H. J., Villarreal-Garza, C., Pagani, O., Paluch-Shimon, S., Ballestrero, A., Del Mastro, L., Piccart-Gebhart, M., Bines, J., Partridge, A. A., & de Azambuja, E. (2022). Impact of Age on Clinical Outcomes and Efficacy of Adjuvant Dual Anti-HER2 Targeted Therapy. Journal of the National Cancer Institute, 114(8), 1117-1126. doi:10.1093/jnci/djac096